Patients Missing, Avoiding Routine Care in Response to Pandemic
More than 10% of survey repondents with chronic illness (eg, asthma, diabetes), would avoid seeking needed care because of fears related to COVID-19.
Patients with chronic conditions, from asthma to type 2 diabetes, are particularly worried about maintaining their health during the COVID-19 pandemic, including seeing their physicians for routine care and access to medications. In fact, on average, 40% are worried/very worried about going to a medical facility, including the ED, for needed care, and more than 10% are so worried they would not seek that care. Nationally, aprpoximately 20% of patients, no matter what their disease state, are worried about managing their health. These findings are based on a survey of 185,000 patients conducted by health and measurement company Evidation Health.
This short slide show summarizes Evidation survey results on COVID-19 impact on heatlhcare utilizatoin obtained between March 12 and April 14, 2020. Data were analyzed across 8 major chronic conditions (the company tracks 39.)
FDA Accepts Protocol for Annovis Bio’s Buntanetap Phase 3 Alzheimer Disease Trial
January 9th 2025Buntanetap is an oral molecule designed to inhibit the production of multiple neurotoxic proteins and is under investigation for treatment of Alzheimer Disease, Parkinson’s Disease, and other neurodegenerative diseases.
